Pre-Endoscopic viral screening of children during the Covid-19 pandemic

dc.contributor.authorDogan, Erkan
dc.contributor.authorSevinc, Eylem
dc.contributor.authorSevinc, Nergiz
dc.contributor.authorBasar, Erhan
dc.date.accessioned2024-09-29T16:09:35Z
dc.date.available2024-09-29T16:09:35Z
dc.date.issued2022
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAim: Transmission of SARS-CoV-2 infection can easily occur through direct or close contact with infected people, just as with other infectious diseases. Therefore, it is important to detect it prior to the intervention for protecting the health of both the healthcare worker and the patient. In the study, it was aimed to determine the seroposidvity rates of acute respiratory syndrome coronavirus 2, hepatitis A, hepatitis 8, hepatitis C virus and human immune deficiency virus infections among children who underwent gastrointestinal endoscopy. Material and Methods: The study was conducted at the Department of Pediatric Gastroenterology of the Karabuk University in Turkey from December 2020 to December of 2021. A total of 175 children were included in the study. The study was divided into three age groups as follows: 1-6 years old, 7-12 years old and 13-18 years old. All children were screened for acute respiratory syndrome coronavirus 2. hepatitis A, hepatitis B, hepatitis C virus and human immune deficiency virus infections. Results: The median age was 12.5 years (1-18). The seroprevalence of acute respiratory syndrome coronavirus 2, Anti-HAV IgM, Anti-HAV IgG, HBsAg, AntiHBs, Anti-HCV, Anti-HIV and were detected 0.57%, 0.57%, 42.8%, 0%, 58.8%. 1.1% and 0 % respectively. The seroprevalence of Anti-HAV IgG was significantly higher in children aged 1-6 years than in the group aged 13-18 years (95.7 vs 25.2: x2=48.1, p=0.001). Discussion: Although seroprevalence rates prior to endoscopy were low in this study, viral screening, except for hepatitis A infection, is essential for the safety of both patients and healthcare.en_US
dc.identifier.doi10.4328/ACAM.21037
dc.identifier.endpage329en_US
dc.identifier.issn2667-663X
dc.identifier.issue3en_US
dc.identifier.startpage325en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.21037
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7637
dc.identifier.volume13en_US
dc.identifier.wosWOS:000782124600021en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEndoscopyen_US
dc.subjectHepatitisen_US
dc.subjectHIVen_US
dc.subjectSARS-CoV-2en_US
dc.subjectScreeningen_US
dc.titlePre-Endoscopic viral screening of children during the Covid-19 pandemicen_US
dc.typeArticleen_US

Dosyalar